Search

Your search keyword '"Pareek K"' showing total 10 results
Start Over Author "Pareek K" Topic atherosclerosis
10 results on '"Pareek K"'

1. Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of India.

Author

Puri R, Mehta V, Duell PB, Wangnoo SK, Rastogi A, Mohan V, Zargar AH, Kalra S, Sahoo AK, Iyengar SS, Yusuf J, Mukhopadhyay S, Singla MK, Shaikh A, Kohli S, Mathur S, Jain S, Narasingan SN, Gupta V, Agarwala R, Mittal V, Varma A, Panda JK, Shetty S, Yadav M, Muruganathan A, Dabla P, Pareek KK, Manoria PC, Nanda R, Sattur GB, Pancholia AK, and Wong ND

Subjects
Humans, Risk Factors, Lipids, India epidemiology, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 epidemiology, Dyslipidemias complications, Dyslipidemias epidemiology, Dyslipidemias therapy, Cardiology, Atherosclerosis complications, Atherosclerosis therapy, Cardiovascular Diseases
Abstract

In 2021 an estimated 74 million individuals had diabetes in India, almost all type 2 diabetes. More than half of patients with diabetes are estimated to be undiagnosed and more 90% have dyslipidemia that is associated with accelerated development of atherosclerotic cardiovascular disease (ASCVD). Patients of Indian descent with diabetes have multiple features that distinguish them from patients with diabetes in Western populations. These include characteristics such as earlier age of onset, higher frequency of features of the metabolic syndrome, more prevalent risk factors for ASCVD, and more aggressive course of ASCVD complications. In light of the unique features of diabetes and diabetic dyslipidemia in individuals of Indian descent, the Lipid Association of India developed this expert consensus statement to provide guidance for management of diabetic dyslipidemia in this very high risk population. The recommendations contained herein are the outgrowth of a series of 165 webinars conducted by the Lipid Association of India across the country from May 2020 to July 2021, involving 155 experts in endocrinology and cardiology and an additional 2880 physicians., Competing Interests: Conflict of interest Raman Puri: Boehringer Ingelheim, Novartis Vimal Mehta: Institutional research grants from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, LIB Therapeutics, Novo Nordisk, Torrent P Barton Duell: Advisory activities: Akcea/Ionis, Esperion, Novo Nordisk, Regeneron, Kaneka. Institutional grants: Regeneron, Regenxbio, Retrophin/Travere V Mohan: Research or educational grants from Abbott, AstraZeneca, Boehringer Ingelheim, Dr. Reddy's Lab, Johnson and Johnson, Lifescan, MSD, Novartis, Novo Nordisk, Roche Diabetes Care India Private Ltd, Sanofi-Aventis, USV, other Indian pharmaceutical companies S. S. Iyengar: Dr. Reddy's Lab, Amgen, Emcure, Glenmark, Boehringer Ingelheim, Pfizer, Novartis Vinod Mittal: Boehringer Ingelheim, USV, Cipla, Intas, Emcure, MacLeods S N Narasingan: USV, Novo Nordisk, Eris, Glenmark, Torrent, Boehringer Ingelheim J.B. Chemicals and Pharmaceuticals Nathan D. Wong: Amgen, Amarin, Novartis, Esperion SK Wangnoo: Sanofi- Aventis, Nova Nordisk, Boehringer Ingelheim, Astra Zeneca The other authors report no conflict of interest., (Copyright © 2022. Published by Elsevier Inc.)

Published
2023
Full Text
View/download PDF

2. Lipoprotein(a) and ASCVD risk.

Author

Puri R, Mehta V, Iyengar SS, Narasingan SN, Duell PB, Sattur GB, Vijayaraghavan K, Mohan JC, Wangnoo SK, Dalal J, Prabhakar D, Agarwal R, Bansal M, Yusuf J, Mukhopadhyay S, Shetty S, Manoria PC, Sabharwal A, Pradhan A, Mehrotra R, Mishra S, Puri S, Muruganathan A, Zargar AH, Patanwala RM, Kumar S, Bardoloi N, Pareek KK, Kapoor A, Rastogi A, Nair DR, Shaikh A, Adhikari CM, Majumder MSM, Kapoor D, Yadav M, Mubarak MR, Pancholia AK, Sahay RK, Nanda R, and Wong ND

Subjects
Humans, Risk Factors, Atherosclerosis, Lipoprotein(a)
Published
2020

3. Lifestyle Modification in the Prevention of Atherosclerotic Cardiovascular Disease.

Author

Puri R, Mehta V, Iyengar SS, Narasingan SN, Duell PB, Sattur GB, Vijayaraghavan K, Mohan JC, Wangnoo SK, Dalal J, Prabhakar D, Agarwal R, Bansal M, Yusuf J, Mukhopadhyay S, Shetty S, Manoria PC, Sabharwal A, Pradhan A, Mehrotra R, Mishra S, Puri S, Muruganathan A, Zargar AH, Patanwala RM, Kumar S, Bardoloi N, Pareek KK, Kapoor A, Rastogi A, Nair DR, Shaikh A, Adhikari CM, Majumder MSM, Kapoor D, Yadav M, Mubarak MR, Pancholia AK, Sahay RK, Nanda R, and Wong ND

Subjects
Humans, Life Style, Primary Prevention, Atherosclerosis prevention & control, Cardiovascular Diseases prevention & control
Published
2020

4. Triglycerides and Atherosclerotic Cardiovascular Disease.

Author

Puri R, Mehta V, Iyengar SS, Narasingan SN, Duell PB, Sattur GB, Vijayaraghavan K, Mohan JC, Wangnoo SK, Dalal J, Prabhakar D, Agarwal R, Bansal M, Yusuf J, Mukhopadhyay S, Shetty S, Manoria PC, Sabharwal A, Pradhan A, Mehrotra R, Mishra S, Puri S, Muruganathan A, Zargar AH, Patanwala RM, Kumar S, Bardoloi N, Pareek KK, Kapoor A, Rastogi A, Nair DR, Shaikh A, Adhikari CM, Majumder MSM, Kapoor D, Yadav M, Mubarak MR, Pancholia AK, Sahay RK, Nanda R, and Wong ND

Subjects
Cholesterol, HDL, Humans, Risk Factors, Triglycerides, Atherosclerosis, Cardiovascular Diseases epidemiology
Published
2020

5. Non-HDL Cholesterol and Atherosclerotic Cardiovascular Disease.

Author

Puri R, Mehta V, Iyengar SS, Narasingan SN, Duell PB, Sattur GB, Vijayaraghavan K, Mohan JC, Wangnoo SK, Dalal J, Prabhakar D, Agarwal R, Bansal M, Yusuf J, Mukhopadhyay S, Shetty S, Manoria PC, Sabharwal A, Pradhan A, Mehrotra R, Mishra S, Puri S, Muruganathan A, Zargar AH, Patanwala RM, Kumar S, Bardoloi N, Pareek KK, Kapoor A, Rastogi A, Nair DR, Shaikh A, Adhikari CM, Majumder MSM, Kapoor D, Yadav M, Mubarak MR, Pancholia AK, Sahay RK, Nanda R, and Wong ND

Subjects
Cholesterol, Cholesterol, HDL, Humans, Risk Factors, Atherosclerosis, Cardiovascular Diseases epidemiology
Published
2020

6. Low Density Lipoprotein Cholesterol Targets in Secondary Prevention of Atherosclerotic Cardiovascular Disease.

Author

Puri R, Mehta V, Iyengar SS, Narasingan SN, Duell PB, Sattur GB, Vijayaraghavan K, Mohan JC, Wangnoo SK, Dalal J, Prabhakar D, Agarwal R, Bansal M, Yusuf J, Mukhopadhyay S, Shetty S, Manoria PC, Sabharwal A, Pradhan A, Mehrotra R, Mishra S, Puri S, Muruganathan A, Zargar AH, Patanwala RM, Kumar S, Bardoloi N, Pareek KK, Kapoor A, Rastogi A, Nair DR, Shaikh A, Adhikari CM, Majumder MSM, Kapoor D, Yadav M, Mubarak MR, Pancholia AK, Sahay RK, Nanda R, and Wong ND

Subjects
Cholesterol, HDL, Cholesterol, LDL, Humans, Secondary Prevention, Atherosclerosis prevention & control, Cardiovascular Diseases prevention & control, Hydroxymethylglutaryl-CoA Reductase Inhibitors
Published
2020

7. Low Density Lipoprotein Cholesterol Targets in Secondary Prevention of Atherosclerotic Cardiovascular Disease

Author

Puri, R., Mehta, V., Iyengar, S. S., Narasingan, S. N., Duell, P. B., Sattur, G. B., Vijayaraghavan, K., Mohan, J. C., Wangnoo, S. K., Dalal, J., Prabhakar, D., Agarwal, R., Bansal, M., Yusuf, J., Mukhopadhyay, S., Shetty, S., Manoria, P. C., Sabharwal, A., Akshyaya Pradhan, Mehrotra, R., Mishra, S., Puri, S., Muruganathan, A., Zargar, A. H., Patanwala, R. M., Kumar, S., Bardoloi, N., Pareek, K. K., Kapoor, A., Rastogi, A., Nair, D. R., Shaikh, A., Adhikari, C. M., Majumder, M. S. M., Kapoor, D., Yadav, M., Mubarak, M. R., Pancholia, A. K., Sahay, R. K., Nanda, R., and Wong, N. D.

Subjects
Cardiovascular Diseases, Cholesterol, HDL, Secondary Prevention, Humans, Cholesterol, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Atherosclerosis

8. Triglycerides and Atherosclerotic Cardiovascular Disease

Author

Puri, R., Mehta, V., Iyengar, S. S., Narasingan, S. N., Duell, P. B., Sattur, G. B., Vijayaraghavan, K., Mohan, J. C., Wangnoo, S. K., Dalal, J., Prabhakar, D., Agarwal, R., Bansal, M., Yusuf, J., Mukhopadhyay, S., Shetty, S., Manoria, P. C., Sabharwal, A., Akshyaya Pradhan, Mehrotra, R., Mishra, S., Puri, S., Muruganathan, A., Zargar, A. H., Patanwala, R. M., Kumar, S., Bardoloi, N., Pareek, K. K., Kapoor, A., Rastogi, A., Nair, D. R., Shaikh, A., Adhikari, C. M., Majumder, M. S. M., Kapoor, D., Yadav, M., Mubarak, M. R., Pancholia, A. K., Sahay, R. K., Nanda, R., and Wong, N. D.

Subjects
Cardiovascular Diseases, Risk Factors, Cholesterol, HDL, Humans, Atherosclerosis, Triglycerides

9. Lifestyle Modification in the Prevention of Atherosclerotic Cardiovascular Disease

Author

Puri, R., Mehta, V., Iyengar, S. S., Narasingan, S. N., Duell, P. B., Sattur, G. B., Vijayaraghavan, K., Mohan, J. C., Wangnoo, S. K., Dalal, J., Prabhakar, D., Agarwal, R., Bansal, M., Yusuf, J., Mukhopadhyay, S., Shetty, S., Manoria, P. C., Sabharwal, A., Akshyaya Pradhan, Mehrotra, R., Mishra, S., Puri, S., Muruganathan, A., Zargar, A. H., Patanwala, R. M., Kumar, S., Bardoloi, N., Pareek, K. K., Kapoor, A., Rastogi, A., Nair, D. R., Shaikh, A., Adhikari, C. M., Majumder, M. S. M., Kapoor, D., Yadav, M., Mubarak, M. R., Pancholia, A. K., Sahay, R. K., Nanda, R., and Wong, N. D.

Subjects
Primary Prevention, Cardiovascular Diseases, Humans, Atherosclerosis, Life Style

10. Lipoprotein(a) and ASCVD risk

Author

Puri, R., Mehta, V., Iyengar, S. S., Narasingan, S. N., Duell, P. B., Sattur, G. B., Vijayaraghavan, K., Mohan, J. C., Wangnoo, S. K., Dalal, J., Prabhakar, D., Agarwal, R., Bansal, M., Yusuf, J., Mukhopadhyay, S., Shetty, S., Manoria, P. C., Sabharwal, A., Akshyaya Pradhan, Mehrotra, R., Mishra, S., Puri, S., Muruganathan, A., Zargar, A. H., Patanwala, R. M., Kumar, S., Bardoloi, N., Pareek, K. K., Kapoor, A., Rastogi, A., Nair, D. R., Shaikh, A., Adhikari, C. M., Majumder, M. S. M., Kapoor, D., Yadav, M., Mubarak, M. R., Pancholia, A. K., Sahay, R. K., Nanda, R., and Wong, N. D.

Subjects
Risk Factors, Humans, Atherosclerosis, Lipoprotein(a)

Catalog

Books, media, physical & digital resources
See catalog results